FDA Inspection 1269887 — Ascension Saint John Medical Center

Ascension Saint John Medical Center — FEI 1671035

The FDA completed an inspection of Ascension Saint John Medical Center on May 9, 2025 in Tulsa, OK. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
May 9, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Tulsa, OK (United States)

Citations

IDCFRDescription
7821 CFR 606.100(c)Record review prior to release
9821 CFR 606.100(c)Thorough investigations

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.